Skip to main content
Premium Trial:

Request an Annual Quote

Illumina to Market GenoLogics' Geneus LIMS

Premium

GenoLogics said this week that Illumina will market a version of its Geneus Laboratory Information Management System software that is preconfigured to handle data from Illumina's HiSeq and Genome Analyzer sequencing platforms and TruSeq sample preparation kits.

The Canadian firm said that its software will enable Illumina users to automate workflows, track library preparations and instrument runs, and prepare basic reports within weeks rather than months.

GenoLogics CEO Michael Ball noted that the combined efforts of the two firms will enable sequencing laboratories to deploy instrumentation and data management tools simultaneously, thus addressing a data-related bottleneck highlighted in a recent survey conducted by JP Morgan.

GenoLogics noted that 63 percent of NGS laboratory directors who participated in the survey identified data storage, data management, and informatics as the "biggest hurdles to expanding next-generation sequencing."

Ball noted that the current arrangement follows an earlier preferred partner agreement between the two companies that made it possible for his firm to develop a version of the LIMS software that is "complementary" to Illumina's sequencing platforms and sample prep kits.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.